Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 109 to 118 of 118 entries
Sorted by: Best Match Show Resources per page
To the Editor: Starting insulin therapy.

Cleveland Clinic journal of medicine

Weiss D.
PMID: 26469814
Cleve Clin J Med. 2015 Oct;82(10):638. doi: 10.3949/ccjm.82c.10001.

No abstract available.

Cite
Weiss D. To the Editor: Starting insulin therapy. Cleve Clin J Med. 2015;82(10):638doi: 10.3949/ccjm.82c.10001.
Weiss, D. (2015). To the Editor: Starting insulin therapy. Cleveland Clinic journal of medicine, 82(10), 638. https://doi.org/10.3949/ccjm.82c.10001
Weiss, Daniel. "To the Editor: Starting insulin therapy." Cleveland Clinic journal of medicine vol. 82,10 (2015): 638. doi: https://doi.org/10.3949/ccjm.82c.10001
Weiss D. To the Editor: Starting insulin therapy. Cleve Clin J Med. 2015 Oct;82(10):638. doi: 10.3949/ccjm.82c.10001. PMID: 26469814.
Copy Download .nbib Format: NLM
Insulin affordability.

The lancet. Diabetes & endocrinology

Hegele RA.
PMID: 28434485
Lancet Diabetes Endocrinol. 2017 May;5(5):324. doi: 10.1016/S2213-8587(17)30115-8.

No abstract available.

Cite
Hegele RA. Insulin affordability. Lancet Diabetes Endocrinol. 2017;5(5):324doi: 10.1016/S2213-8587(17)30115-8.
Hegele, R. A. (2017). Insulin affordability. The lancet. Diabetes & endocrinology, 5(5), 324. https://doi.org/10.1016/S2213-8587(17)30115-8
Hegele, Robert A. "Insulin affordability." The lancet. Diabetes & endocrinology vol. 5,5 (2017): 324. doi: https://doi.org/10.1016/S2213-8587(17)30115-8
Hegele RA. Insulin affordability. Lancet Diabetes Endocrinol. 2017 May;5(5):324. doi: 10.1016/S2213-8587(17)30115-8. PMID: 28434485.
Copy Download .nbib Format: NLM
Acylated-based long-acting insulin analogues: is “misfolding” the problem? Commentary letter on Hamasaki H and Yanai H. The switching from insulin glargine to insulin degludec reduced HbA1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes.

Diabetes & metabolism

Monnier L, Colette C, Owens D.
PMID: 25459321
Diabetes Metab. 2014 Dec;40(6):483-4. doi: 10.1016/j.diabet.2014.10.001.

No abstract available.

Cite
Monnier L, Colette C, Owens D. Acylated-based long-acting insulin analogues: is “misfolding” the problem? Commentary letter on Hamasaki H and Yanai H. The switching from insulin glargine to insulin degludec reduced HbA1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes. Diabetes Metab. 2014;40(6):483-4doi: 10.1016/j.diabet.2014.10.001.
Monnier, L., Colette, C., & Owens, D. (2014). Acylated-based long-acting insulin analogues: is “misfolding” the problem? Commentary letter on Hamasaki H and Yanai H. The switching from insulin glargine to insulin degludec reduced HbA1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes. Diabetes & metabolism, 40(6), 483-4. https://doi.org/10.1016/j.diabet.2014.10.001
Monnier, L, et al. "Acylated-based long-acting insulin analogues: is “misfolding” the problem? Commentary letter on Hamasaki H and Yanai H. The switching from insulin glargine to insulin degludec reduced HbA1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes." Diabetes & metabolism vol. 40,6 (2014): 483-4. doi: https://doi.org/10.1016/j.diabet.2014.10.001
Monnier L, Colette C, Owens D. Acylated-based long-acting insulin analogues: is “misfolding” the problem? Commentary letter on Hamasaki H and Yanai H. The switching from insulin glargine to insulin degludec reduced HbA1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes. Diabetes Metab. 2014 Dec;40(6):483-4. doi: 10.1016/j.diabet.2014.10.001. PMID: 25459321.
Copy Download .nbib Format: NLM
Red Blood Cells for Glucose-Responsive Insulin Delivery.

Advanced materials (Deerfield Beach, Fla.)

Wang C, Ye Y, Sun W, Yu J, Wang J, Lawrence DS, Buse JB, Gu Z.
PMID: 28267235
Adv Mater. 2017 May;29(18). doi: 10.1002/adma.201606617. Epub 2017 Mar 07.

Glucose-responsive delivery of insulin mimicking the function of pancreatic β-cells to achieve meticulous control of blood glucose (BG) would revolutionize diabetes care. Here the authors report the development of a new glucose-responsive insulin delivery system based on the potential...

Cite
Wang C, Ye Y, Sun W, et al. Red Blood Cells for Glucose-Responsive Insulin Delivery. Adv Mater. 2017;29(18)doi: 10.1002/adma.201606617.
Wang, C., Ye, Y., Sun, W., Yu, J., Wang, J., Lawrence, D. S., Buse, J. B., & Gu, Z. (2017). Red Blood Cells for Glucose-Responsive Insulin Delivery. Advanced materials (Deerfield Beach, Fla.), 29(18), . https://doi.org/10.1002/adma.201606617
Wang, Chao, et al. "Red Blood Cells for Glucose-Responsive Insulin Delivery." Advanced materials (Deerfield Beach, Fla.) vol. 29,18 (2017). doi: https://doi.org/10.1002/adma.201606617
Wang C, Ye Y, Sun W, Yu J, Wang J, Lawrence DS, Buse JB, Gu Z. Red Blood Cells for Glucose-Responsive Insulin Delivery. Adv Mater. 2017 May;29(18). doi: 10.1002/adma.201606617. Epub 2017 Mar 07. PMID: 28267235.
Copy Download .nbib Format: NLM
Cystic Fibrosis-Related Diabetes in Children: An Update.

Pediatric annals

Kim RJ.
PMID: 27622916
Pediatr Ann. 2016 Sep 01;45(9):e321-6. doi: 10.3928/19382359-20160815-01.

Cystic fibrosis-related diabetes mellitus (CFRD) is the most common endocrine complication of cystic fibrosis (CF), affecting more than 50% of patients by the 4th decade of life. CFRD is often preceded by worsening pulmonary status and nutritional decline. Treatment...

Cite
Kim RJ. Cystic Fibrosis-Related Diabetes in Children: An Update. Pediatr Ann. 2016;45(9):e321-6doi: 10.3928/19382359-20160815-01.
Kim, R. J. (2016). Cystic Fibrosis-Related Diabetes in Children: An Update. Pediatric annals, 45(9), e321-6. https://doi.org/10.3928/19382359-20160815-01
Kim, Roy J. "Cystic Fibrosis-Related Diabetes in Children: An Update." Pediatric annals vol. 45,9 (2016): e321-6. doi: https://doi.org/10.3928/19382359-20160815-01
Kim RJ. Cystic Fibrosis-Related Diabetes in Children: An Update. Pediatr Ann. 2016 Sep 01;45(9):e321-6. doi: 10.3928/19382359-20160815-01. PMID: 27622916.
Copy Download .nbib Format: NLM
[Current status and perspective of bariatric surgery in the treatment of type 1 diabetes with obesity].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Wang L, Jiang T, Wang J.
PMID: 30269329
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Sep 25;21(9):1075-1080.

With the development of social economy and the change of lifestyle and working environment, the number of obese and diabetic population has increased significantly. Obesity is closely related to diabetes mellitus with interaction. Among the patients with type 1...

Cite
Wang L, Jiang T, Wang J. [Current status and perspective of bariatric surgery in the treatment of type 1 diabetes with obesity]. Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(9):1075-1080
Wang, L., Jiang, T., & Wang, J. (2018). [Current status and perspective of bariatric surgery in the treatment of type 1 diabetes with obesity]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 21(9), 1075-1080.
Wang, Lun, et al. "[Current status and perspective of bariatric surgery in the treatment of type 1 diabetes with obesity]." Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery vol. 21,9 (2018): 1075-1080.
Wang L, Jiang T, Wang J. [Current status and perspective of bariatric surgery in the treatment of type 1 diabetes with obesity]. Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Sep 25;21(9):1075-1080. Chinese. PMID: 30269329.
Copy Download .nbib Format: NLM
Evaluation of current trends and recent development in insulin therapy for management of diabetes mellitus.

Diabetes & metabolic syndrome

Nawaz MS, Shah KU, Khan TM, Rehman AU, Rashid HU, Mahmood S, Khan S, Farrukh MJ.
PMID: 28709853
Diabetes Metab Syndr. 2017 Dec;11:S833-S839. doi: 10.1016/j.dsx.2017.07.003. Epub 2017 Jul 08.

OBJECTIVE: Diabetes mellitus is a major health problem in developing countries. There are various insulin therapies to manage diabetes mellitus. This systematic review evaluates various insulin therapies for management of diabetes mellitus worldwide. This review also focuses on recent...

Cite
Nawaz MS, Shah KU, Khan TM, et al. Evaluation of current trends and recent development in insulin therapy for management of diabetes mellitus. Diabetes Metab Syndr. 2017;11:S833-S839doi: 10.1016/j.dsx.2017.07.003.
Nawaz, M. S., Shah, K. U., Khan, T. M., Rehman, A. U., Rashid, H. U., Mahmood, S., Khan, S., & Farrukh, M. J. (2017). Evaluation of current trends and recent development in insulin therapy for management of diabetes mellitus. Diabetes & metabolic syndrome, 11S833-S839. https://doi.org/10.1016/j.dsx.2017.07.003
Nawaz, Muhammad Sarfraz, et al. "Evaluation of current trends and recent development in insulin therapy for management of diabetes mellitus." Diabetes & metabolic syndrome vol. 11 (2017): S833-S839. doi: https://doi.org/10.1016/j.dsx.2017.07.003
Nawaz MS, Shah KU, Khan TM, Rehman AU, Rashid HU, Mahmood S, Khan S, Farrukh MJ. Evaluation of current trends and recent development in insulin therapy for management of diabetes mellitus. Diabetes Metab Syndr. 2017 Dec;11:S833-S839. doi: 10.1016/j.dsx.2017.07.003. Epub 2017 Jul 08. PMID: 28709853.
Copy Download .nbib Format: NLM
Mapping of Type 1 Diabetes Mellitus.

Current diabetes reviews

Desai S, Deshmukh A.
PMID: 31584373
Curr Diabetes Rev. 2020;16(5):438-441. doi: 10.2174/1573399815666191004112647.

Type 1 diabetes mellitus (T1DM), an autoimmune disorder, is becoming widespread with approximately 97,700 children in India and 490,000 children worldwide affected. There are various etiological factors contributing to the expansion of its incidence on different geographical locations. Hence,...

Cite
Desai S, Deshmukh A. Mapping of Type 1 Diabetes Mellitus. Curr Diabetes Rev. 2020;16(5):438-441doi: 10.2174/1573399815666191004112647.
Desai, S., & Deshmukh, A. (2020). Mapping of Type 1 Diabetes Mellitus. Current diabetes reviews, 16(5), 438-441. https://doi.org/10.2174/1573399815666191004112647
Desai, Shivani, and Deshmukh, Atul. "Mapping of Type 1 Diabetes Mellitus." Current diabetes reviews vol. 16,5 (2020): 438-441. doi: https://doi.org/10.2174/1573399815666191004112647
Desai S, Deshmukh A. Mapping of Type 1 Diabetes Mellitus. Curr Diabetes Rev. 2020;16(5):438-441. doi: 10.2174/1573399815666191004112647. PMID: 31584373.
Copy Download .nbib Format: NLM
Modeling Patient Journeys for Demand Segments in Chronic Care, With an Illustration to Type 2 Diabetes.

Frontiers in public health

Elkhuizen SG, Vissers JMH, Mahdavi M, van de Klundert JJ.
PMID: 33014961
Front Public Health. 2020 Aug 28;8:428. doi: 10.3389/fpubh.2020.00428. eCollection 2020.

Chronic care is an important area for cost-effective and efficient health service delivery. Matching demand and services for chronic care is not easy as patients may have different needs in different stages of the disease. More insight is needed...

Cite
Elkhuizen SG, Vissers JMH, Mahdavi M, et al. Modeling Patient Journeys for Demand Segments in Chronic Care, With an Illustration to Type 2 Diabetes. Front Public Health. 2020;8:428doi: 10.3389/fpubh.2020.00428.
Elkhuizen, S. G., Vissers, J. M. H., Mahdavi, M., & van de Klundert, J. J. (2020). Modeling Patient Journeys for Demand Segments in Chronic Care, With an Illustration to Type 2 Diabetes. Frontiers in public health, 8428. https://doi.org/10.3389/fpubh.2020.00428
Elkhuizen, Sylvia G, et al. "Modeling Patient Journeys for Demand Segments in Chronic Care, With an Illustration to Type 2 Diabetes." Frontiers in public health vol. 8 (2020): 428. doi: https://doi.org/10.3389/fpubh.2020.00428
Elkhuizen SG, Vissers JMH, Mahdavi M, van de Klundert JJ. Modeling Patient Journeys for Demand Segments in Chronic Care, With an Illustration to Type 2 Diabetes. Front Public Health. 2020 Aug 28;8:428. doi: 10.3389/fpubh.2020.00428. eCollection 2020. PMID: 33014961; PMCID: PMC7493672.
Copy Download .nbib Format: NLM
Attaining maximum benefit from insulin therapy.

Contemporary internal medicine

Piziak VK.
PMID: 10150336
Contemp Intern Med. 1995 Feb;7(2):28-34, 39-42.

No abstract available.

Cite
Piziak VK. Attaining maximum benefit from insulin therapy. Contemp Intern Med. 1995;7(2):28-34, 39-42
Piziak, V. K. (1995). Attaining maximum benefit from insulin therapy. Contemporary internal medicine, 7(2), 28-34, 39-42.
Piziak, V K. "Attaining maximum benefit from insulin therapy." Contemporary internal medicine vol. 7,2 (1995): 28-34, 39-42.
Piziak VK. Attaining maximum benefit from insulin therapy. Contemp Intern Med. 1995 Feb;7(2):28-34, 39-42. PMID: 10150336.
Copy Download .nbib Format: NLM
Showing 109 to 118 of 118 entries